Eastwood Bio-Medical Canada Inc.
EWOOF · OTC
7/31/2024 | 4/30/2024 | 1/31/2024 | 10/31/2023 | |
|---|---|---|---|---|
| Market Cap | $66 | $66 | $64 | $115 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $66 | $66 | $64 | $115 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 39.2% | -32.7% | 55.7% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 69.5% | 63.9% | 69.8% | 38.3% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -39.6% | -79.3% | -18.6% | -106.6% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -61.4% | -96.3% | -27% | -142.7% |
| EPS Diluted | -0.001 | -0.001 | -0.001 | -0.002 |
| % Growth | 14.3% | -133.3% | 68.4% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | $0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | $0 | -$0 | $0 |